Critical residues of epitopes recognized by several anti-p53 monoclonal antibodies correspond to key residues of p53 involved in interactions with the mdm2 protein

Journal of Immunological Methods

Volumn 244, Issue 1-2, 2000, Pages 17-28

  Portefaix, Jean Michel ^a   Thebault, Sabine ^a   Bourgain Guglielmetti, Florence ^b   Del Rio, Maguy ^a   Granier, Claude ^a   Mani, Jean Claude ^a   Navarro Teulon, Isabelle ^a   Nicolas, Michel ^a   Soussi, Thierry ^b   Pau, Bernard ^a  

^a CENTRE VAL D AURELLE   (France)

^b INSTITUT CURIE   (France)

Author keywords

mdm2; Monoclonal antibody; p53; Spot; Surface plasmon resonance

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; PROTEIN MDM2; PROTEIN P53;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSS REACTION; HUMAN; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RABBIT; SURFACE PLASMON RESONANCE; XENOPUS;

ALANINE; AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BINDING SITES; CONSENSUS SEQUENCE; CROSS REACTIONS; EPITOPE MAPPING; HUMAN; IMMUNODOMINANT EPITOPES; KINETICS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN P53; PROTO-ONCOGENE PROTEINS; RABBITS; SUPPORT, NON-U.S. GOV'T; XENOPUS;

MURINAE; ORYCTOLAGUS CUNICULUS;

EID: 0034693432     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(00)00246-5     Document Type: Article

References (37)

1. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression
2. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies
3. p53 and APC gene mutations: software and databases
4. Regulation of the specific DNA binding activity of Xenopus laevis p53: evidence for conserved regulation through the carboxy-terminus of the protein
5. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity
6. Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B-cell lymphoma
7. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
8. Clinical utility of the immunocytochemical detection of p53 protein in cytological specimens
9. Mimicry between receptors and antibodies. Identification of snake toxin determinants recognized by the acetylcholine receptor and an acetylcholine receptor-mimicking monoclonal antibody
10. Spot synthesis: an easy technique for positionally addressable, parallel chemical synthesis on membrane support
11. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form
12. A complementary-determining region peptide of antidesmosome autoantibody may interact with the desmosomal plaque through molecular mimicry with a cytoplasmic desmoglein 1 sequence
13. Cell cycle control and cancer
14. Mdm2 promotes the rapid degradation of p53
15. Regulation of p53 stability by Mdm2
16. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
17. On the expression of the p53 protein in human cancer
18. Epitope analysis of the murine p53 tumour suppressor protein
19. Production of human p53 specific monoclonal antibodies and their use in immunohistochemical studies of tumor cells
20. Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein
21. Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein
22. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein
23. Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface
24. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding
25. Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes
26. Improved performances of spot multiple peptide synthesis
27. Immunochemical analysis of the interaction of p53 with MDM2; fine mapping of the MDM2 binding site on p53 using synthetic peptides
28. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot
29. Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein
30. The humoral response to the tumor-suppressor gene-product p53 in human cancer: implications for diagnosis and therapy
31. Structural aspects of the p53 protein in relation to gene evolution: a second look
32. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions
33. Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library
34. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60
35. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53
36. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein
37. Precise epitope mapping of the murine transformation-associated protein, p53